VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AUTL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AUTLAutolus Therapeutics plc
$1.28$341M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAUTLQuarterly Cash Flow

Autolus Therapeutics plc (AUTL) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Autolus Therapeutics plc (AUTL) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

AUTL Cash Flow Statement

Quarterly statement

AUTL Cash Flow Statement

Autolus Therapeutics plc (AUTL) cash flow statement — 11-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-25.07M-65.32M-67.32M-67.9M-72.78M-75.56M-37.93M-76.74M-51.08M-40.51M-24.83M-40.19M-38.15M-42.42M-14.57M-31.9M-30.81M-35.03M-9.16M-34.75M
Operating CF Margin %-54.87%-249.13%-277.58%-320.37%-347.85%-841.29%-130806.9%---401.49%--9898.52%--3283.2%-380.81%-1346.73%---5087.78%-14724.15%
Operating CF Growth %65.56%13.56%-77.47%11.52%-42.48%-86.52%-52.76%-90.95%-33.91%4.49%-70.49%-25.97%-23.82%-21.09%-59.05%8.19%15.85%6.19%66.97%11.04%
Net Income-39.11M-71.6M-90.33M-79.11M-47.92M-70.16M-27.61M-82.09M-58.27M-52.69M-77.17M-45.85M-45.55M-39.81M-26.95M-42.77M-42.06M-37.06M-41.67M-33.99M
Depreciation & Amortization2.65M2.7M2.63M3.38M4.31M2.28M2.08M1.94M4.18M1.81M1.77M1.38M1.51M1.9M1.65M1.79M1.92M2.07M2.1M2.45M
Stock-Based Compensation4.59M3.56M3.44M3.83M4.29M2.87M6.23M4.02M2.94M2.28M3.27M2.86M2.66M2.41M3.42M3.34M2.92M2.34M7.83M1.5M
Deferred Taxes788K-16K-1.17M13K384K487K141K-168K74K-232K-466K-238K-87K-195K319K-160K-253K-174K-420K233K
Other Non-Cash Items-896K16.51M17.06M-36.63M-10.93M6.66M-15.79M-2.44M8.91M22.07M26.92M12.38M2.65M6.73M-2.57M7.12M7.05M1.79M1.09M1K
Working Capital Changes6.91M-16.48M1.05M40.62M-22.92M-17.7M-2.99M2M-8.92M-13.75M20.83M-10.72M668K-13.45M9.57M-1.22M-388K-3.99M21.91M-4.94M
Change in Receivables-16.74M-3.63M8.57M-6M-12.39M-14.34M00000000000000
Change in Inventory-1.19M-2.54M029.12M-11.44M-10.1M00000000000000
Change in Payables-667K-1.17M-7.52M5.42M1.53M1.86M331K276K-335K1.32M-578K-3.19M3.49M-227K109K232K-47K-272K0503K
Cash from Investing67.9M96.15M86.54M35.55M95.92M-59.55M-383.59M-9.59M-841K-533K-1.48M-1.5M-4.39M-3.62M-633K-6.8M-2.64M-771K-1.58M-3.86M
Capital Expenditures-913K0-23.76M15.52M-7.28M-8.24M-11.11M-9.59M-841K-533K-1.48M-1.5M-4.39M-3.62M-633K-6.8M-2.64M-771K-1.58M-3.86M
CapEx % of Revenue2%10.24%97.98%73.23%34.78%91.77%38317.24%--5.28%-368.97%-280.34%16.55%286.91%--880.56%1636.02%
Acquisitions00000000000000000000
Investments--------------------
Other Investing0-2.69M24.65M-28.02M00-372.48M0000000000000
Cash from Financing-2.14M-2.06M-1.8M-1.77M-768K030.01M185K-2.08M561.44M23K4K-219K-691K223.51M102K0-1K147.41M-230K
Debt Issued (Net)0-2.06M000000000000000000
Equity Issued (Net)3K000000185K0549.98M04K0-691K163.85M0-1K00-712K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-2.14M-3.46K-1.8M-1.77M-768K030.01M0-2.08M11.46M23K0-219K059.66M102K1K-1K147.41M482K
Net Change in Cash40.49M26.78M18.01M-37.71M28.08M-131.55M-429.73M-48.42M-52.59M519.21M-16.51M-50.98M-35.52M-39.41M219.39M-53.39M-52.13M-41.78M137.41M-43.29M
Free Cash Flow-25.98M-68M-91.09M-52.38M-80.06M-83.81M-61.79M-86.33M-51.92M-41.05M-26.31M-41.69M-42.54M-46.04M-15.2M-38.7M-33.45M-35.8M-10.74M-38.61M
FCF Margin %-56.87%-259.37%-375.55%-247.14%-382.63%-933.07%-213068.97%---406.77%--10267.49%--3563.54%-397.36%-1633.64%---5968.33%-16360.17%
FCF Growth %67.55%18.86%-47.41%39.33%-54.18%-104.18%-134.85%-107.09%-22.07%10.85%-73.1%-7.71%-27.17%-28.6%-41.48%-0.24%12.26%8.77%67.64%10.44%
FCF per Share-0.10-0.26-0.34-0.20-0.30-0.31-0.23-0.32-0.20-0.18-0.15-0.24-0.24-0.26-0.13-0.42-0.37-0.39-0.15-0.53
FCF Conversion (FCF/Net Income)0.64x0.91x0.75x0.86x1.52x1.08x1.37x0.93x0.88x0.77x0.32x0.88x0.84x1.07x0.54x0.75x0.73x0.95x0.22x1.02x
Interest Paid00000000000000000000
Taxes Paid00001.03M9K00984K00000000000